Novo’s Ozempic copy 15% cheaper, but Discovery still won’t change its position

Cheaper diabetes drug arrives, but Discovery sees little reason to widen patient cover

Novo’s Ozempic copy 15% cheaper, but Discovery still won’t change its position
Cheaper diabetes drug arrives, but Discovery sees little reason to widen patient cover